(Q64150280)
Statements
Phase 2, Placebo-Controlled, Parallel Group Dose-Finding Study to Evaluate the Efficacy and Safety of Three Dose Levels of AD036 in Adults With Obstructive Sleep Apnea (English)
0 references
7 March 2019
0 references
30 September 2019
0 references
140
0 references
25 year
0 references
70 year
0 references